XSHE
000691
Market cap616mUSD
Oct 09, Last price
8.73CNY
1D
2.59%
1Q
-23.29%
Jan 2017
-18.03%
Name
Gansu Yatai Industrial Development Co Ltd
Chart & performance
P/E
—
P/S
8.13
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
-0.02%
Revenues
521m
+17.61%
Net income
-36m
L-65.91%
CFO
14m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gansu Yatai Industrial Developent Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of fine chemical products in China, the rest of Asia, South America, and Europe. The company offers pyridine derivatives, nitrated derivatives, and other chemical products, as well as pharmaceutical intermediates and pesticide intermediates. It serves the pesticide, medicine, and feed additives industries. The company was formerly known as Hainan Yatai Industrial Development Co., Ltd. and changed its name to Gansu Yatai Industrial Development Co.,Ltd. in December 2021. Gansu Yatai Industrial Developent Co.,Ltd. was founded in 1988 and is based in Guangzhou, China.
Key people
Bing Ma
Vice Chairman of the Board · since 2025
Yongliang Li
Deputy General Manager, Director · since 2025
Shuhan Yang
Deputy General Manager · since 2022
Weiyuan Yang
Chief Financial Officer, Deputy General Manager · since 2023
Qin Zhong
Deputy General Manager · since 2023
Xiaohui Li
Secretary of the Board · since 2023
Zhijian Chen
Chairman of the Board · since 2023
Wei'an Chen
Director · since 2023
Qixing Chen
Director · since 2025
Xiaomin Liu
Director · since 2023
Yong Zhao
Director · since 2023
Jiangfeng Gong
Independent Director · since 2023
Shunxian Liu
Independent Director · since 2023
Cuilin Wang
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||